Enfusion, Inc.

Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to Infusion's third quarter 2023 earnings conference call. At this time, all lines have been placed on mute to prevent any background noise. Following the speaker's remarks, we will open the lines for your questions. As a reminder, this conference call is being recorded. I'd now like to turn the call over to Ignatius Njoku, head of investor relations, to begin.

Good morning, and thank you, Operator.

We welcome you to Infusion's third quarter 2023 earnings conference call. Hosting today's call are Oleg Mokshin, Infusion's chief executive officer, and Brad Herron, Infusion's chief financial officer. Please note, our quarterly shareholder letter, which includes our quarterly financial results, have all been posted to our IR website. I would like to remind you that today's call may contain forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC and are available in the Investor Relations section in our website. Actual results may differ materially from any forward-looking statements we make today. These forward-looking statements speak only as of today when the company does not assume any obligation or intent to update them following today's call, except as required by law. In addition, today's call may include non-GAAP measures. These measures should be considered as a supplement to and not a substitute for GAAP financial measures. Conciliation to the nearest GAAP measure can be found in today's quarterly shareholder letter, which is available on the company's website. With that, I'd like to turn the call over to Oleg to begin.